PA8680201A1 - Proceso de elaboración para tigeciclina - Google Patents
Proceso de elaboración para tigeciclinaInfo
- Publication number
- PA8680201A1 PA8680201A1 PA20068680201A PA8680201A PA8680201A1 PA 8680201 A1 PA8680201 A1 PA 8680201A1 PA 20068680201 A PA20068680201 A PA 20068680201A PA 8680201 A PA8680201 A PA 8680201A PA 8680201 A1 PA8680201 A1 PA 8680201A1
- Authority
- PA
- Panama
- Prior art keywords
- tigecicline
- elaboration process
- elaboration
- adequate
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
- C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
- C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
Abstract
SE DESCRIBE AQUÍ UN PROCESO DE ELABORACIÓN PARA LA PREPARACIÓN DE TIGECICLINA ADECUADO PARA LA INFUSIÓN INTRAVENOSA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69117305P | 2005-06-16 | 2005-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8680201A1 true PA8680201A1 (es) | 2007-01-17 |
Family
ID=37111782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20068680201A PA8680201A1 (es) | 2005-06-16 | 2006-06-16 | Proceso de elaboración para tigeciclina |
Country Status (22)
Country | Link |
---|---|
US (1) | US7705168B2 (es) |
EP (1) | EP1898884A2 (es) |
JP (3) | JP2008543871A (es) |
KR (1) | KR20080024201A (es) |
CN (1) | CN101198315A (es) |
AR (1) | AR055336A1 (es) |
AU (1) | AU2006261636A1 (es) |
BR (1) | BRPI0612228A2 (es) |
CA (1) | CA2610909A1 (es) |
CR (1) | CR9594A (es) |
EC (1) | ECSP078005A (es) |
GT (1) | GT200600259A (es) |
IL (1) | IL187979A0 (es) |
MX (1) | MX2007015960A (es) |
NO (1) | NO20076264L (es) |
PA (1) | PA8680201A1 (es) |
PE (1) | PE20070072A1 (es) |
RU (1) | RU2007145595A (es) |
SV (1) | SV2007002575A (es) |
TW (1) | TW200716203A (es) |
WO (1) | WO2006138641A2 (es) |
ZA (1) | ZA200710906B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070244335A1 (en) * | 2006-04-17 | 2007-10-18 | Teva Pharmaceutical Industries Ltd. | Isolation of tetracycline derivatives |
US8198470B2 (en) * | 2006-04-24 | 2012-06-12 | Teva Pharmaceutical Industries Ltd. | Crystalline form II of tigecycline and processes for preparation thereof |
TW200812943A (en) * | 2006-04-24 | 2008-03-16 | Teva Pharma | Processes for preparation of tigecycline crystalline forms I and II |
EP2086926A2 (en) * | 2006-11-29 | 2009-08-12 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of tigecycline and processes for preparation thereof |
US20080234504A1 (en) * | 2006-11-30 | 2008-09-25 | Evgeny Tsiperman | Processes for preparation of 9-haloacetamidominocyclines |
WO2008106234A1 (en) * | 2007-03-01 | 2008-09-04 | Teva Pharmaceutical Industries Ltd. | Processes for purification of tigecycline |
US20090099376A1 (en) * | 2007-10-16 | 2009-04-16 | Wyeth | Tigecycline and methods of preparing intermediates |
US9107929B2 (en) | 2008-05-01 | 2015-08-18 | Ranbaxy Laboratories Limited | Stable parenteral formulations of tigecycline |
ITMI20080807A1 (it) | 2008-05-05 | 2009-11-06 | Antibioticos Spa | Procedimento per la preparazione di tigeciclina in forma amorfa |
WO2010017273A2 (en) * | 2008-08-06 | 2010-02-11 | Wyeth | Tigecycline formulations |
PT104350A (pt) | 2009-01-23 | 2010-07-23 | Hovione Farmaci Ncia S A | Processo de isolamento de tigeciclina |
CA2751238A1 (en) | 2009-03-12 | 2010-10-07 | Wyeth Llc | Nitration of tetracyclines |
CN103417498B (zh) * | 2012-05-18 | 2017-09-12 | 山东新时代药业有限公司 | 一种替加环素冻干粉针剂的制备方法 |
IN2013MU01127A (es) | 2013-03-26 | 2015-05-01 | Astron Res Ltd | |
WO2014167575A2 (en) | 2013-03-26 | 2014-10-16 | Astron Research Limited | Stable tigecycline composition |
CN103202814A (zh) * | 2013-04-23 | 2013-07-17 | 成都百裕科技制药有限公司 | 一种注射用替加环素的制备方法 |
CN105924367B (zh) * | 2016-04-18 | 2017-12-29 | 镇江高海生物药业有限公司 | 多西环素一水物的有关物质及其分析检测方法 |
WO2019147755A1 (en) * | 2018-01-26 | 2019-08-01 | AL Pharma, Inc. | Manufacturing and packaging of a sterile drug product |
CN108653216B (zh) * | 2018-05-28 | 2020-12-18 | 福安药业集团湖北人民制药有限公司 | 注射用替加环素 |
WO2021063468A1 (en) | 2019-10-02 | 2021-04-08 | Anfarm Hellas S.A. | Stable parenteral pharmaceutical composition containing tigecycline and process for the preparation thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3026248A (en) | 1959-09-11 | 1962-03-20 | Pfizer & Co C | Thioglycerol and formaldehyde sulfoxylate stabilized tetracycline antibiotics in polyhydric alcohol solvents |
US5494903A (en) | 1991-10-04 | 1996-02-27 | American Cyanamid Company | 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
US5284963A (en) | 1992-08-13 | 1994-02-08 | American Cyanamid Company | Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines |
US6660267B1 (en) * | 1992-12-21 | 2003-12-09 | Promega Corporation | Prevention and treatment of sepsis |
US5675030A (en) | 1994-11-16 | 1997-10-07 | American Cyanamid Company | Method for selective extracting a 7-(hydrogen or substituted amino)-9- (substituted glycyl) amido!-6-demethyl-6-deoxytetracycline compound |
CA2490062A1 (en) * | 2002-05-23 | 2003-12-04 | Activbiotics, Inc. | Methods of treating bacterial infections and diseases associated therewith |
BRPI0517406A (pt) * | 2004-10-28 | 2008-10-07 | Wyeth Corp | método de tratamento, controle ou redução do risco de uma infecção bacteriana e um estado de insuficiência cardìaca em um ser humano; método para controle do aumento dos nìveis plasmáticos de digoxina em estado constante em um ser humano; método de tratamento, controle ou redução do risco de uma infecção bacteriana com tigeciclina em um paciente; uso de tigeciclina em combinação com digoxina; e produto compreendendo tigeciclina e digoxina como uma preparação combinada |
GT200600112A (es) * | 2005-03-14 | 2006-11-29 | Composiciiones de tigeciclina y metodos de preparacion | |
AR057034A1 (es) | 2005-05-27 | 2007-11-14 | Wyeth Corp | Metodos para purificar tigeciclina |
-
2006
- 2006-06-15 AR ARP060102533A patent/AR055336A1/es unknown
- 2006-06-15 PE PE2006000670A patent/PE20070072A1/es not_active Application Discontinuation
- 2006-06-16 CN CNA2006800213849A patent/CN101198315A/zh active Pending
- 2006-06-16 EP EP06773424A patent/EP1898884A2/en not_active Withdrawn
- 2006-06-16 MX MX2007015960A patent/MX2007015960A/es unknown
- 2006-06-16 JP JP2008517178A patent/JP2008543871A/ja active Pending
- 2006-06-16 PA PA20068680201A patent/PA8680201A1/es unknown
- 2006-06-16 WO PCT/US2006/023613 patent/WO2006138641A2/en active Application Filing
- 2006-06-16 BR BRPI0612228-0A patent/BRPI0612228A2/pt not_active IP Right Cessation
- 2006-06-16 SV SV2006002575A patent/SV2007002575A/es unknown
- 2006-06-16 US US11/455,144 patent/US7705168B2/en not_active Expired - Fee Related
- 2006-06-16 TW TW095121834A patent/TW200716203A/zh unknown
- 2006-06-16 KR KR1020087001124A patent/KR20080024201A/ko not_active Application Discontinuation
- 2006-06-16 CA CA002610909A patent/CA2610909A1/en not_active Abandoned
- 2006-06-16 AU AU2006261636A patent/AU2006261636A1/en not_active Abandoned
- 2006-06-16 GT GT200600259A patent/GT200600259A/es unknown
- 2006-06-16 RU RU2007145595/15A patent/RU2007145595A/ru not_active Application Discontinuation
-
2007
- 2007-12-05 NO NO20076264A patent/NO20076264L/no not_active Application Discontinuation
- 2007-12-06 IL IL187979A patent/IL187979A0/en unknown
- 2007-12-12 EC EC2007008005A patent/ECSP078005A/es unknown
- 2007-12-14 CR CR9594A patent/CR9594A/es unknown
- 2007-12-14 ZA ZA200710906A patent/ZA200710906B/xx unknown
-
2009
- 2009-06-05 JP JP2009136753A patent/JP2009191083A/ja not_active Withdrawn
- 2009-11-05 JP JP2009254475A patent/JP2010024252A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AR055336A1 (es) | 2007-08-22 |
US20070026080A1 (en) | 2007-02-01 |
RU2007145595A (ru) | 2009-07-27 |
CN101198315A (zh) | 2008-06-11 |
KR20080024201A (ko) | 2008-03-17 |
JP2010024252A (ja) | 2010-02-04 |
EP1898884A2 (en) | 2008-03-19 |
AU2006261636A1 (en) | 2006-12-28 |
PE20070072A1 (es) | 2007-02-25 |
JP2009191083A (ja) | 2009-08-27 |
IL187979A0 (en) | 2008-03-20 |
GT200600259A (es) | 2007-05-08 |
SV2007002575A (es) | 2007-01-03 |
WO2006138641A2 (en) | 2006-12-28 |
ZA200710906B (en) | 2009-03-25 |
JP2008543871A (ja) | 2008-12-04 |
CR9594A (es) | 2008-03-07 |
MX2007015960A (es) | 2008-03-06 |
CA2610909A1 (en) | 2006-12-28 |
TW200716203A (en) | 2007-05-01 |
BRPI0612228A2 (pt) | 2011-03-29 |
WO2006138641A3 (en) | 2007-05-18 |
US7705168B2 (en) | 2010-04-27 |
NO20076264L (no) | 2008-03-10 |
ECSP078005A (es) | 2008-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8680201A1 (es) | Proceso de elaboración para tigeciclina | |
LTPA2020536I1 (lt) | Nauji anti-CD38 antikūnai, skirti vėžio gydymui | |
AR110313A2 (es) | Derivados de tiazol-2-il-pirrolidina | |
CY1118343T1 (el) | Αντισωματα συνδεσης twεακ | |
TW200617019A (en) | A process for the preparation of 7α-alkylated 19-norsteroids | |
CR10157A (es) | Compuestos químicos | |
RS52784B (en) | They're TANATE RAZAGILINA | |
EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
TW200731094A (en) | Extensible meta-data | |
NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
ME01992B (me) | Jedinjenje diarilhidantoina | |
EA200802213A1 (ru) | Способы лечения заболеваний крови | |
AR063188A1 (es) | Compuestos intermediarios para la preparacion de trans -5-cloro-2-netil-2,3,3a,12b- tetrahidro-1h-dibenz (2,3:6,7)- oxepina (4,5c) pirrol | |
CY1111793T1 (el) | Μυκητοκτονες συνθεσεις | |
CY1112467T1 (el) | Παραγωγα 1-θειο-d-γλυκιτολης | |
EA201001402A1 (ru) | Фармацевтические растворы, способ получения и терапевтическое применение | |
EA200702529A1 (ru) | Фунгицидная комбинация биологически активных веществ | |
AR058253A1 (es) | Procedimiento para la preparacion de ferri-succinilcaseina | |
AR069531A1 (es) | Derivados de indolinona y procedimiento para su fabricacion | |
CY1106579T1 (el) | Μεθοδος για την παρασκευη συμπλοκων 1,2-διαμινοκυκλοεξανιου-δισθενους πλατινης | |
NO20090738L (no) | Tilveiebringelse av EP2 agonister, fremgangsmate for fremstilling derav, farmasoytiske sammensetninger inneholdende disse forbindelser og fremgangsmater for anvendelse av forbindelsene og sammensetningene for a senke intraokkulaert trykk og behandle glaukom | |
EA200971068A1 (ru) | Триазолиламинопиримидиновые соединения | |
AR061446A1 (es) | Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico | |
CR10548A (es) | 18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen | |
EA200700766A1 (ru) | Способ получения производных [1,4,5]-оксадиазепина |